Pill tested to clear painful nail psoriasis
NCT ID NCT05124080
Summary
This small, early-stage study tested whether a daily pill called deucravacitinib could improve nail psoriasis. Adult patients with significant nail and skin psoriasis took the pill for 48 weeks. Researchers tracked changes in nail appearance and pain to see if the treatment was helpful and safe.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NAIL PSORIASIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Alabama at Birmingham - Department of Dermatology
Birmingham, Alabama, 35233, United States
Conditions
Explore the condition pages connected to this study.